FibroGen Inc. (FGEN)
0.30
-0.00 (-0.03%)
At close: Apr 02, 2025, 3:59 PM
0.29
-4.92%
Pre-market: Apr 03, 2025, 07:51 AM EDT
FibroGen Inc. Revenue Breakdown
| Quarter | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Product Revenue Revenue | -262K | 24.49M | 1.05M | 1.32M | 14.27M | 2.11M | 6.48M | 1.09M | 7.59M | 1.13M | 13.44M | -8.65M | 8.48M | 35.92M | 686K | 8.24M | 5.37M | 579K |
| Drug Product Revenue Revenue Growth | -101.07% | +2227.57% | -20.30% | -90.75% | +576.72% | -67.43% | +492.50% | -85.61% | +572.04% | -91.59% | -255.43% | -201.98% | -76.39% | +5136.44% | -91.67% | +53.35% | +827.81% | n/a |
| Product Revenue | 46.21M | 30.54M | n/a | 29.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13.37M | n/a | n/a | 27.9M | 19.83M | n/a | n/a |
| Product Revenue Growth | +51.32% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +40.67% | n/a | n/a | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|
| China Revenue | 109.38M | 84.63M | 55.64M | 72.5M | 132.4M | 112.92M | 16.89M | 25.78M |
| China Revenue Growth | +29.24% | +52.10% | -23.25% | -45.24% | +17.26% | +568.74% | -34.50% | n/a |
| Europe Revenue | 9.55M | 33.82M | 131.24M | 67.16M | n/a | n/a | n/a | n/a |
| Europe Revenue Growth | -71.77% | -74.23% | +95.42% | n/a | n/a | n/a | n/a | n/a |
| Japan Revenue | 15.87M | 9.76M | 2.31M | 36.66M | n/a | n/a | n/a | n/a |
| Japan Revenue Growth | +62.51% | +323.60% | -93.71% | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 12.96M | 12.52M | 46.12M | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +3.53% | -72.86% | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 17.55M | 22.28M | 22.82M | 24.22M | 25.57M | 31.18M | 34.27M | 33.97M | 29.9M | 30.26M | 30.56M | 34.74M | 25.85M | 32.55M | 30.78M | 42.25M | -48.98M | 63.53M | 49.6M | 50.71M | 35.82M | 26.74M | 22.21M | 17.85M | 15.36M | 15.05M | 15.55M | 13.85M | 12.95M | 13.43M | 11.53M | 12.59M | 11.65M | 10.38M | 11.42M | 12.96M | 11.24M | 9.68M | 10.48M |
| Selling, General, and Administrative Revenue Growth | -21.20% | -2.38% | -5.79% | -5.28% | -17.99% | -9.03% | +0.91% | +13.59% | -1.18% | -1.00% | -12.02% | +34.37% | -20.58% | +5.77% | -27.15% | -186.26% | -177.09% | +28.09% | -2.18% | +41.55% | +33.97% | +20.39% | +24.42% | +16.25% | +2.00% | -3.18% | +12.27% | +6.93% | -3.52% | +16.44% | -8.38% | +8.06% | +12.24% | -9.12% | -11.94% | +15.38% | +16.08% | -7.65% | n/a |
| Research and Development Revenue | 21.71M | 34.11M | 38.39M | 51.7M | 61.19M | 95.48M | 74.49M | 61.63M | 75.18M | 70.96M | 89.02M | 113.92M | 75.88M | 122.57M | 74.68M | 78.13M | 58.48M | 61.41M | 54.9M | 56.8M | 49.96M | 52.01M | 50.5M | 70.28M | 56.44M | 52.14M | 56.97M | 52.47M | 50.34M | 46.98M | 46.73M | 50.61M | 40.56M | 52.39M | 43.65M | 59.92M | 52.07M | 51.55M | 50.54M |
| Research and Development Revenue Growth | -36.35% | -11.16% | -25.75% | -15.51% | -35.91% | +28.18% | +20.86% | -18.03% | +5.95% | -20.28% | -21.86% | +50.13% | -38.09% | +64.13% | -4.42% | +33.62% | -4.78% | +11.86% | -3.34% | +13.68% | -3.93% | +2.99% | -28.15% | +24.52% | +8.26% | -8.49% | +8.59% | +4.24% | +7.14% | +0.53% | -7.66% | +24.78% | -22.59% | +20.03% | -27.16% | +15.08% | +1.00% | +2.01% | n/a |